High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism
Shirai, N.; Furuta, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60 Suppl. 2: 439-444
2002
ISSN/ISBN: 0047-1852 PMID: 11979823 Document Number: 543676
Document emailed within 1 workday
Related Documents
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602
Cui, M.; Hu, F.; Jiang, H.; Zheng, X. 2002: Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection Zhonghua Yi Xue Za Zhi 82(18): 1245-1248
Laine, L.; Stein, C.; Neil, G. 1995: Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing "optimal" dosing American Journal of Gastroenterology 90(9): 1407-1410
Tursi, A.; Cammarota, G.; Papa, A.; Montalto, M.; Veneto, G.; Capelli, G.; Cuoco, L.; Branca, G.; Fedeli, G.; Gasbarrini, G. 1996: One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection Hepato-Gastroenterology 43(10): 859-862
Brzozowski, T.; Konturek, P.C.; Kwiecien, S.; Konturek, S.J.; Pajdo, R.; Drozdowicz, D.; Ptak, A.; Pawlik, M.; Stachura, J.; Pawlik, W.W.; Hahn, E.G. 2003: Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 54(1): 33-51
Adamek, R.J.; Opferkuch, W.; Wegener, M. 1995: Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection American Journal of Gastroenterology 90(1): 168-169
Fattahi, E.; Motamedi, R.; Nayebi, A.R.M.; Rezazadeh, H.; Shakir, A. 2004: Triple therapy using two dosages of metronidazole along with amoxicillin and omeprazole to eradicate Helicobacter pylori infection: a randomized, open study Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 23(4): 154
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Sanfélix Genovés, J.; Pereiró Berenguer, I.; Jimeno Bernard, R.; García Tell, G.; Navarro Pérez, J.; Bonet Pla, A.; Ballester Belenguer, J. 1998: Helicobacter pylori: 6-day triple therapy in duodenal ulcer Atencion Primaria 21(8): 517-521
Ren, Q.; Ma, B.; Yang, K.; Yan, X. 2010: Lafutidine-based triple therapy for Helicobacter pylori eradication Hepato-Gastroenterology 57: 102-103
Kimura, K.; Ido, K.; Saifuku, K.; Taniguchi, Y.; Kihira, K.; Satoh, K.; Takimoto, T.; Yoshida, Y. 1995: A 1-h topical therapy for the treatment of Helicobacter pylori infection American Journal of Gastroenterology 90(1): 60-63
Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G. 1993: Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease Medizinische Klinik 88(5): 297-299
Flores, S.; Opazo, H.; Valderrama, D.; Aguilera, R.; Marchese, A.; Valderrama, S. 2000: Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori Revista Medica de Chile 128(5): 509-512
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235
Thong-Ngam, D.; Tangkijvanich, P.; Treeprasertsuk, S.; Wisedopas, N.; Kullavanijaya, P. 2002: Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori Journal of the Medical Association of Thailand 85(10): 1054-1059
Duggan, A.; Williamson, R. 1998: Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori Gut 42(4): 596-597
Asano, M.; Taniwaki, H.; Tsuji, D.; Sato, Y.; Shimizu, T. 2005: Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 12): 450-453
Dorval, E.D.; Loulergue, J.; Barbieux, J.P.; Metman, E.H.; de Muret, A. 1991: Helicobacter pylori and duodenal ulcer. Long-term results of triple sucralfate antibiotic therapy Gastroenterologie Clinique et Biologique 15(11): 863-864
Karita, M.; Morshed, M.G.; Ouchi, K.; Okita, K. 1994: Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate American Journal of Gastroenterology 89(7): 1032-1035